Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
Ke-Hung TsuiYing-Ling ChangTsui-Hsia FengChen-Pang HouYu-Hsiang LinPei-Shan YangBing-Wei LeeHorng-Heng JuangPublished in: The Prostate (2017)
Our results indicated that Cap inhibited growth of LNCaP cells. Cap effectively suppressed androgen activation on AR-mediated transactivation, which is AR-dependent through AR degradation and dissociation of AR-Hsp90 in prostate carcinoma cells.